Revvity, Inc. is a leading health science solutions provider offering products and services spanning discovery, development, diagnosis, and treatment. The company operates two segments—Life Sciences and Diagnostics—delivering reagents, instruments, software, and services including BioLegend antibodies, HTRF assay technologies, Opera Phenix imaging systems, newborn screening solutions, and informatics platforms. Revvity serves pharmaceutical, biotech, academic, government, and clinical customers in over 160 countries.
expected 2027-02-02
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | RVTY | discussed Healthcare & Bio | |
| topic_mention | RVTY | discussed Artificial Intelligence | |
| topic_mention | RVTY | discussed Cloud Computing | |
| topic_mention | RVTY | discussed Regulation | |
| topic_mention | RVTY | discussed Healthcare & Bio | |
| topic_mention | RVTY | discussed Artificial Intelligence | |
| topic_mention | RVTY | discussed Regulation | |
| topic_mention | RVTY | discussed Healthcare & Bio | |
| topic_mention | RVTY | discussed Platform & Ecosystem | |
| metric | RVTY gross margin | reported $28.0 percent | |
| topic_mention | RVTY | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | RVTY | discussed Cloud Computing | Q4 FY2025 |
| topic_mention | RVTY | discussed Cybersecurity | Q4 FY2025 |
| topic_mention | RVTY | discussed Blockchain & Crypto | Q4 FY2025 |
| topic_mention | RVTY | discussed Capital Expenditure | Q4 FY2025 |
| topic_mention | RVTY | discussed Supply Chain | Q4 FY2025 |
| topic_mention | RVTY | discussed Regulation | Q4 FY2025 |
| topic_mention | RVTY | discussed Sovereign & Government | Q4 FY2025 |
| topic_mention | RVTY | discussed Automotive | Q4 FY2025 |
| topic_mention | RVTY | discussed Healthcare & Bio | Q4 FY2025 |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-28 | 0000031791-26-000012 | EDGAR | 53K words |
| 2025-02-25 | 2024-12-29 | 0000031791-25-000009 | EDGAR | 52K words |
| 2024-02-27 | 2023-12-31 | 0000031791-24-000004 | EDGAR | 56K words |
| 2023-03-01 | 2023-01-01 | 0000031791-23-000004 | EDGAR | 71K words |
| 2022-03-03 | 2022-01-02 | 0000031791-22-000003 | EDGAR | 70K words |
| 2021-03-02 | 2021-01-03 | 0000031791-21-000003 | EDGAR | 90K words |
| 2020-02-25 | 2019-12-29 | 0000031791-20-000003 | EDGAR | 90K words |
| 2019-02-26 | 2018-12-30 | 0000031791-19-000003 | EDGAR | 96K words |
| 2018-02-27 | 2017-12-31 | 0000031791-18-000004 | EDGAR | 92K words |
| 2017-02-28 | 2017-01-01 | 0000031791-17-000003 | EDGAR | 92K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-10 | 2026-10-04 | 0000031791-26-000034 | EDGAR | 24K words |
| 2026-08-11 | 2026-07-05 | 0000031791-26-000027 | EDGAR | 24K words |
| 2025-11-04 | 2025-09-28 | 0000031791-25-000037 | EDGAR | 24K words |
| 2025-08-05 | 2025-06-29 | 0000031791-25-000026 | EDGAR | 23K words |
| 2025-05-06 | 2025-03-30 | 0000031791-25-000015 | EDGAR | 21K words |
| 2024-11-06 | 2024-09-29 | 0000031791-24-000028 | EDGAR | 24K words |
| 2024-08-06 | 2024-06-30 | 0000031791-24-000021 | EDGAR | 24K words |
| 2024-05-07 | 2024-03-31 | 0000031791-24-000014 | EDGAR | 21K words |
| 2023-11-07 | 2023-10-01 | 0000031791-23-000014 | EDGAR | 30K words |
| 2023-08-09 | 2023-07-02 | 0000031791-23-000011 | EDGAR | 92K words |
| 2023-05-12 | 2023-04-02 | 0000031791-23-000008 | EDGAR | 27K words |
| 2022-11-14 | 2022-10-02 | 0000031791-22-000012 | EDGAR | 35K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-13 | 0001628280-26-073578 | EDGAR | 0K words |
| 2026-11-03 | 0000031791-26-000031 | EDGAR | 11K words |
| 2026-08-04 | 0000031791-26-000022 | EDGAR | 11K words |
| 2026-02-02 | 0000031791-26-000007 | EDGAR | 9K words |
| 2026-01-13 | 0000031791-26-000003 | EDGAR | 1K words |
| 2025-10-27 | 0000031791-25-000032 | EDGAR | 8K words |
| 2025-10-24 | 0001193125-25-249958 | EDGAR | 1K words |
| 2025-07-28 | 0000031791-25-000022 | EDGAR | 8K words |
| 2025-04-28 | 0000031791-25-000012 | EDGAR | 7K words |
| 2025-04-25 | 0001193125-25-096747 | EDGAR | 18K words |
219 total filings indexed. 187 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | RVTY Earnings Call Transcript | |
| — | RVTY Earnings Call Transcript | |
| — | Q4 FY2025 | RVTY Q4 FY2025 Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000031791 |
| Ticker | RVTY |
| Exchange | NYSE |
| SIC | 3826: Laboratory Analytical Instruments |
| Incorporated | MA |
| Headquarters | Waltham, Massachusetts |
| Website | https://www.revvity.com |
| Listed | 1972-06-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RVTY (~200 tokens, structured JSON with cryptographic provenance)